# NCT06146777 (NCT06146777)

> Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06146777
- Phase: PHASE3
- Status: NOT_YET_RECRUITING
- Sponsor: First Affiliated Hospital, Sun Yat-Sen University
- Conditions: Papillary Renal Cell Carcinoma
- Interventions: Pembrolizumab; Placebo
- Enrollment: 468
- Primary outcome: Disease-free survival

## Indexed commentary on NCT06146777 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 2 posts on X
- 1 post on Bluesky

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct06146777